The measurement and valuation of health status using EQ-5D : a European perspective : evidence from the EuroQol BIOMED Research Programme

EQ-5D from the EuroQol Group is a standardised, non-disease-specific instrument for describing and valuing health. It is in widespread use in many countries and has been applied in many different settings. EQ-5D is now an integral feature of many clinical trials and is increasingly used in population health surveys. This book reports on the results of the European Union-funded EQ-net project which furthered the development of EQ-5D in the key areas of valuation, application and translation. The primary effort concentrated on harmonising and integrating the results of the various EuroQol valuation projects. Most importantly, the book includes a set of VAS-based preference weights for all the EQ-5D health states based on cross-European EQ-5D data. This book provides the most comprehensive account to date of the EuroQol Group endeavour. It will appeal to clinicians, nurses, health services researchers, health economists, those responsible for audit and quality assurance, public health specialists and managers in health care institutions, and the pharmaceutical industry.

EQ-5D from the EuroQol Group is a standardised, non-disease-specific instrument for describing and valuing health. It is in widespread use in many countries and has been applied in many different settings. EQ-5D is now an integral feature of many clinical trials and is increasingly used in population health surveys.

This book reports on the results of the European Union-funded EQ-net project which furthered the development of EQ-5D in the key areas of valuation, application and translation. The primary effort concentrated on harmonising and integrating the results of the various EuroQol valuation projects. Most importantly, the book includes a set of VAS-based preference weights for all the EQ-5D health states based on cross-European EQ-5D data.

This book provides the most comprehensive account to date of the EuroQol Group endeavour. It will appeal to clinicians, nurses, health services researchers, health economists, those responsible for audit and quality assurance, public health specialists and managers in health care institutions, and the pharmaceutical industry.

Front Matter....Pages i-xx Introduction....Pages 1-5 Guidelines for analysing and reporting EQ-5D outcomes....Pages 7-19 EQ-5D: Modes of administration....Pages 21-27 Guidelines for value sets in economic and non-economic studies using EQ-5D....Pages 29-41 Test-retest performance of EQ-5D....Pages 43-54 Construction of the EQ-net VAS and TTO databases....Pages 55-79 Comparison of EQ-5D VAS valuations: analysis of background variables....Pages 81-101 A European EQ-5D VAS valuation set....Pages 103-142 A comparison of EQ-5D time trade-off values obtained in Germany, The United Kingdom and Spain....Pages 143-165 What concepts does the EQ-5D measure? Intentions and interpretations....Pages 167-182 Producing other language versions of the EQ-5D....Pages 183-189 Exploring the results of translating the EQ-5D into 11 European languages....Pages 191-205 EQ-5D in selected countries around the world....Pages 207-227 Summary and future EQ-5D work....Pages 229-244 Back Matter....Pages 245-303